# Ajanta Pharma Limited · 66-41 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Ajanta Pharma Limited · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product code is 65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient; date published is 09/30/2009; address is 318 Linking Road , Mumbai, INDIA, verified against its source on 2026-09-16.

- **Firm:** Ajanta Pharma Limited _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** 318 Linking Road , Mumbai, INDIA _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient _(verified: appears in the quote below)_
- **FDA notes:** Kamagra 100mg oral tablet; 4/4/2003 _(verified: appears in the quote below)_

## What the source says

> Ajanta Pharma Limited Date Published : 09/30/2009 318 Linking Road , Mumbai, INDIA 65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient Date Published: 09/13/2019 Notes: Kamagra 100mg oral tablet; 4/4/2003

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).